Prospective dengue seroprevalence study in 5 to 10 year-old children

Completed

• Conditions: Dengue

• Registration Number: CTRI/2011/12/002243
• Lead Sponsor: Sanofi Pasteur SA

Brief Summary

This is a descriptive prospective community-based seroprevalence study in a sample of children registered in the health centers to assess the prevalence of dengue-specific antibodies in order to assess if there has been dengue transmission in the community in recent years.xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09-22
• Last Update Posted: 2014-09-18

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 3230

Inclusion Criteria

• Aged between 5 and 10 year-old on the day of inclusion.
• Healthy child as reported by the parent or legally qualified guardian.
• Being registered in selected study site.
• Provision of the informed consent form signed by at least one parent or legally qualified guardian.
• For children between 8 and 10 years old, provision of the assent form signed.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of participants with dengue specific IgG antibodies in serum samples	Day 0

Secondary Outcome Measures

Name	Time	Method
Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4	Day 0
Prevalence of positive serum samples with JEV specific IgG antibodies	Day 0

Trial Locations

Locations (1)

Department of Community Medicine, Maulana Azad Medical College; 🇮🇳 Delhi, DELHI, India

Department of Community Medicine, Maulana Azad Medical College

🇮🇳Delhi, DELHI, India

Dr Suneela Garg

Principal investigator

911123234939

gargsuneela@gmail.com